Sunday, September 17, 2000
14:00-16:00

Glaxo Wellcome Sponsored Symposium

A Middle Eastern buffet will be served from 13:00 outside the Queen of Sheba ballroom

Translating the genetic code for type 2 diabetes
Allen Roses, USA

Insulin resistance the impact on the clinical course of type 2 diabetes
Ele Ferrannini, Italy

Targeting the human PPARg receptor - new drugs by design
Timothy Willson, USA

Future patterns of care - reaching new therapeutic targets with monotherapy
Philip Home, UK

Future patterns of care - combining the benefits of treatment
Itamar Raz, Israel

Beyond glycaemic control - the management of dyslipidaemia with insulin-sensitizing agent
John Betteridge, UK

Questions and panel discussion

Queen of Sheba Ballroom, Renaissance Hotel, Jerusalem

Philip Home, UK
Itamar Raz, Israel

Glaxo Wellcome plc

FOR GENERAL, REGISTRATION AND ABSTRACT ENQUIRIES
Charlotte Taylor or Terri Young
Glaxo Wellcome plc, Stockley Park West
Uxbridge, Middlesex, UB11 1BT, UK
Tel: +44 208 990 9000
e-mail: team@medicalaction.co.uk